We performed auricular excision, total parathyroidecto- my, and extended radical neck dissection in a 36-year- old male patient who developed auricular malignant melanoma.Reconstruction of the surgical defect was made with a split-thickness skin graft. The patient received radiotherapy and chemotherapy after surgery.No evidence of local recurrences or distant metastasis was detected during a follow-up period of 14 months.
Bogle M, Kelly P, Shenaq J, Friedman J, Evans GR. The role of soft tissue reconstruction after melanoma resec- tion in the head and neck. Head Neck 2001;23:8-15.
Johnson TM, Smith JW 2nd, Nelson BR, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995;32(5 Pt 1):689-707.
Weinstock MA. Death from skin cancer among the elderly: epidemiological patterns. Arch Dermatol 1997;133:1207-9.
O'Brien CJ, Coates AS, Petersen-Schaefer K, Shannon K, Thompson JF, Milton GW, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-4.
Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ, Murad TM, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982;196:677-84.
Cohen MH, Ketcham AS, Felix EL, Li SH, Tomaszewski MM, Costa J, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977;186:635-42.
Callery C, Cochran AJ, Roe DJ, Rees W, Nathanson SD, Benedetti JK, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982;196:69-75.
Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenec- tomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491-9.
Balch CM, Murad TM, Soong SJ, Ingalls AL, Richards PC, Maddox WA. Tumor thickness as a guide to surgi- cal management of clinical stage I melanoma patients. Cancer 1979;43:883-8.
Elder DE, Guerry D 4th, Heiberger RM, LaRossa D, Goldman LI, Clark WH Jr, et al. Optimal resection m a rgin for cutaneous malignant melanoma. Plast Reconstr Surg 1983;71:66-72.
Hudson DA, Krige JE, Strover RM, King HS. Malignant melanoma of the external ear. Br J Plast Surg 1990;43:608-11.
Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a ran- domised trial. WHO Melanoma Programme. Lancet 1998;351:793-6.
D e m i e r re MF, Koh HK. Adjuvant therapy for cutaneous malignant melanoma. J Am Acad Dermatol 1997;36(5 Pt 1 ) : 7 4 7 - 6 4 .
Bogle M, Kelly P, Shenaq J, Friedman J, Evans GR. The role of soft tissue reconstruction after melanoma resec- tion in the head and neck. Head Neck 2001;23:8-15.
O'Brien CJ, Petersen-Schaefer K, Stevens GN, Bass PC, Tew P, Gebski VJ, et al. Adjuvant radiotherapy follow- ing neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 1997;19:589-94.
Colmerauer ME, Koziol JA, Pilch YH. Enhancement of metastasis development by BCG immunotherapy. J Surg Oncol 1980;15:235-41.
Auriküler malign melanoma
Year 2002,
Volume: 9 Issue: 1, 63 - 65, 03.01.2002
Auriküler malign melanom tanısı konan 36 yaflında- ki erkek hastaya, aurikula eksizyonu, total parotidek- tomi ve geniflletilmifl radikal boyun diseksiyonu uy- gulandı ve cerrahi sonrasında oluflan defekt, kısmi kalınlıkta deri grefti ile onarıldı. Ameliyat sonrasında radyoterapi ve kemoterapi uygulanan hastanın 14 aylık takibinde lokal nüks veya uzak metastaz sap- tanmadı
Bogle M, Kelly P, Shenaq J, Friedman J, Evans GR. The role of soft tissue reconstruction after melanoma resec- tion in the head and neck. Head Neck 2001;23:8-15.
Johnson TM, Smith JW 2nd, Nelson BR, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995;32(5 Pt 1):689-707.
Weinstock MA. Death from skin cancer among the elderly: epidemiological patterns. Arch Dermatol 1997;133:1207-9.
O'Brien CJ, Coates AS, Petersen-Schaefer K, Shannon K, Thompson JF, Milton GW, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-4.
Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ, Murad TM, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982;196:677-84.
Cohen MH, Ketcham AS, Felix EL, Li SH, Tomaszewski MM, Costa J, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977;186:635-42.
Callery C, Cochran AJ, Roe DJ, Rees W, Nathanson SD, Benedetti JK, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982;196:69-75.
Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenec- tomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491-9.
Balch CM, Murad TM, Soong SJ, Ingalls AL, Richards PC, Maddox WA. Tumor thickness as a guide to surgi- cal management of clinical stage I melanoma patients. Cancer 1979;43:883-8.
Elder DE, Guerry D 4th, Heiberger RM, LaRossa D, Goldman LI, Clark WH Jr, et al. Optimal resection m a rgin for cutaneous malignant melanoma. Plast Reconstr Surg 1983;71:66-72.
Hudson DA, Krige JE, Strover RM, King HS. Malignant melanoma of the external ear. Br J Plast Surg 1990;43:608-11.
Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a ran- domised trial. WHO Melanoma Programme. Lancet 1998;351:793-6.
D e m i e r re MF, Koh HK. Adjuvant therapy for cutaneous malignant melanoma. J Am Acad Dermatol 1997;36(5 Pt 1 ) : 7 4 7 - 6 4 .
Bogle M, Kelly P, Shenaq J, Friedman J, Evans GR. The role of soft tissue reconstruction after melanoma resec- tion in the head and neck. Head Neck 2001;23:8-15.
O'Brien CJ, Petersen-Schaefer K, Stevens GN, Bass PC, Tew P, Gebski VJ, et al. Adjuvant radiotherapy follow- ing neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 1997;19:589-94.
Colmerauer ME, Koziol JA, Pilch YH. Enhancement of metastasis development by BCG immunotherapy. J Surg Oncol 1980;15:235-41.
Aygenç, E., Dakak, Y., & Özdem, C. (2002). Auriküler malign melanoma. The Turkish Journal of Ear Nose and Throat, 9(1), 63-65.
AMA
Aygenç E, Dakak Y, Özdem C. Auriküler malign melanoma. Tr-ENT. January 2002;9(1):63-65.
Chicago
Aygenç, Erdinç, Yasemin Dakak, and Cafer Özdem. “Auriküler Malign Melanoma”. The Turkish Journal of Ear Nose and Throat 9, no. 1 (January 2002): 63-65.
EndNote
Aygenç E, Dakak Y, Özdem C (January 1, 2002) Auriküler malign melanoma. The Turkish Journal of Ear Nose and Throat 9 1 63–65.
IEEE
E. Aygenç, Y. Dakak, and C. Özdem, “Auriküler malign melanoma”, Tr-ENT, vol. 9, no. 1, pp. 63–65, 2002.
ISNAD
Aygenç, Erdinç et al. “Auriküler Malign Melanoma”. The Turkish Journal of Ear Nose and Throat 9/1 (January 2002), 63-65.
JAMA
Aygenç E, Dakak Y, Özdem C. Auriküler malign melanoma. Tr-ENT. 2002;9:63–65.
MLA
Aygenç, Erdinç et al. “Auriküler Malign Melanoma”. The Turkish Journal of Ear Nose and Throat, vol. 9, no. 1, 2002, pp. 63-65.
Vancouver
Aygenç E, Dakak Y, Özdem C. Auriküler malign melanoma. Tr-ENT. 2002;9(1):63-5.